hV01

recombinant human IL-21-expressing oncolytic vaccinia virus · Hangzhou Converd Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for hV01, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer [Phase 2]

See pricing